코로나19 백신 개발사 큐어백 “임상시험서 면역반응” German biotech company, CureVac, recorded an immune reaction from a potential vaccine in a clinical trial on Monday. According to local media outlets, its CEO Franz-Werner Haas was encouraged by the interim results from…
COVID-19 <%ec%b9%98%eb%a3%8c%ec%a0%9c class="post-title"> First Americans could be vaccinated on Dec. 11 %ec%b9%98%eb%a3%8c%ec%a0%9c>